Suchergebnisse - "Spinner, Christoph D"

PubPharm (15)

1

Use and effectiveness of remdesivir for the treatment of patients with covid-19 using data from the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS) : a multicentre cohort study

enthalten in: Infection | 2023

von Pilgram, L. | Appel, K. | Ruethrich, M. | +15

2

Prediction of COVID-19 deterioration in high-risk patients at diagnosis : an early warning score for advanced COVID-19 developed by machine learning

enthalten in: Infection | 2022

von Jakob, C. | Mahajan, U. | Oswald, M. | +78

3

HIV pre-exposure prophylaxis was associated with no impact on sexually transmitted infection prevalence in a high-prevalence population of predominantly men who have sex with men, Germany, 2018 to 2019

enthalten in: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin | 2022

von Streeck, H. | Jansen, K. | Crowell, T. | +19

4

Evaluation of a multiplex PCR screening approach to identify community-acquired bacterial co-infections in COVID-19 : a multicenter prospective cohort study of the German competence network of community-acquired pneumonia (CAPNETZ)

enthalten in: Infection | 2021

von Rothe, K. | Spinner, C. | Panning, M. | +60

5

Switching to a NRTI-free 2 drug regimen (2DR) -a sub-analysis of the 48 weeks DUALIS study on metabolic and renal changes

enthalten in: HIV research & clinical practice | 2021

von Monin, M. | Kümmerle, T. | Schneider, J. | +16

6

The impact of the SARS-CoV-2 pandemic on the prevalence of respiratory tract pathogens in patients with community-acquired pneumonia in Germany

enthalten in: Emerging microbes & infections | 2021

von Dähne, T. | Bauer, W. | Essig, A. | +8

7

Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER) : a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial

enthalten in: The Lancet. Respiratory medicine | 2021

von Marconi, V. | Ramanan, A. | de Bono, S. | +105

CommentIn: Lancet Respir Med. 2021 Dec;9(12):1349-1351. - PMID 34480862

8

Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality

enthalten in: The Journal of clinical investigation | 2021

von Nakanishi, T. | Pigazzini, S. | Degenhardt, F. | +146

UpdateOf: medRxiv. 2021 Mar 12;:. - PMID 33758887

9

Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis : week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial

enthalten in: The lancet. HIV | 2021

von Ogbuagu, O. | Ruane, P. | Podzamczer, D. | +118

ErratumIn: Lancet HIV. 2021 Dec;8(12):e734. - PMID 34571044

10

Immune deficiency is a risk factor for severe COVID-19 in people living with HIV

enthalten in: HIV medicine | 2021

von Hoffmann, C. | Casado, J. | Härter, G. | +8